Ionis Pharmaceuticals, Inc. Earnings

Ionis Pharmaceuticals, Inc.’s revenue jumped 17.12% since last year same period to $156.72Mn in the Q3 2025. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated -65.33% fall in its revenue since last 3-months.

Ionis Pharmaceuticals, Inc.’s net profit jumped 8.45% since last year same period to $-128.61Mn in the Q3 2025. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated -204.09% fall in its net profits since last 3-months.

Ionis Pharmaceuticals, Inc.’s net profit margin jumped 21.83% since last year same period to -82.06% in the Q3 2025. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated -400.25% fall in its net profit margins since last 3-months.

Ionis Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at -1.22 - a -408.33% fall from last quarter’s estimates.

Ionis Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at -1.22.

Ionis Pharmaceuticals, Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Ionis Pharmaceuticals, Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.